Growing community of inventors

Jeddah, Saudi Arabia

Moustafa El-Sayed El-Araby

Average Co-Inventor Count = 3.33

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Moustafa El-Sayed El-Araby ↔ Martin K Safo (5 patents)Moustafa El-Sayed El-Araby ↔ Abdelsattar Mansour Ebeid Omar (4 patents)Moustafa El-Sayed El-Araby ↔ Yan Zhang (1 patent)Moustafa El-Sayed El-Araby ↔ Osheiza Abdulmalik (1 patent)Moustafa El-Sayed El-Araby ↔ Mohini Ghatge (1 patent)Moustafa El-Sayed El-Araby ↔ Abdelsattar Mansour Ebid Omar (1 patent)Moustafa El-Sayed El-ArabyMoustafa El-Sayed El-Araby (5 patents)Martin K SafoMartin K Safo (30 patents)Abdelsattar Mansour Ebeid OmarAbdelsattar Mansour Ebeid Omar (4 patents)Yan ZhangYan Zhang (14 patents)Osheiza AbdulmalikOsheiza Abdulmalik (5 patents)Mohini GhatgeMohini Ghatge (3 patents)Abdelsattar Mansour Ebid OmarAbdelsattar Mansour Ebid Omar (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. King Abdulaziz University (5 from 587 patents)

2. Virginia Commonwealth University (3 from 402 patents)

3. The Children's Hospital of Philadelphia (1 from 282 patents)


5 patents:

1. 11319292 - Metabolically stable 5-HMF derivatives for the treatment of hypoxia

2. 11149012 - Metabolically stable 5-HMF derivatives for the treatment of hypoxia

3. 11104632 - Metabolically stable vanillin derivatives for the treatment of hypoxia

4. 10836729 - Metabolically stable 5-HMF derivatives for the treatment of hypoxia

5. 10344001 - Azolylacryloyl derivatives as therapeutic agents for sickle cell disease

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/16/2025
Loading…